High Court Quashes Criminal Complaint Against Dr. Johns Pvt. Ltd. Due to Prosecutorial Delay

The High Court of Jammu & Kashmir and Ladakh has ruled that the prosecution of pharmaceutical manufacturers cannot be sustained if administrative delays by state authorities deprive the accused of their fundamental right to challenge test reports. Justice Sanjay Dhar delivered the judgment, which quashed a criminal complaint brought by the Drugs Inspector, Zone-3, Srinagar, against Dr. Johns Pvt. Ltd.

A Dispute Over Quality and Time

The legal battle originated from a 2014 routine inspection of M/S JAF, where samples of "CADCAL Capsules" were collected. Subsequent analysis by the Government Analyst declared the drug to be "not of standard quality." The investigation proceeded to trace the supply chain through M/S Sane Enterprises and M/S King Fisher Pharma, eventually implicating the manufacturer, Dr. Johns Pvt. Ltd.

The primary contention rested on the fact that by the time the manufacturer was formally notified of the adverse report and the complaint was filed, the drug’s shelf life had long expired, rendering the statutory right to re-test the sample impossible.

Arguments from Both Sides

Dr. Johns Pvt. Ltd. argued that the trial Magistrate acted in violation of the law by taking cognizance of the offence long after the statutory period of limitation had lapsed. Furthermore, the petitioner contended that the delay in communication and filing meant they were denied their valuable right under Section 25(3) of the Drugs and Cosmetics Act, 1940, to adduce evidence in controversion of the government report.

Conversely, the state argued that the prosecution followed the necessary procedures to trace the chain of supply and that the complaint was legally instituted after obtaining the required sanctions.

Legal Reasoning and Analysis

Justice Sanjay Dhar emphasized that Section 25(3) of the Drugs and Cosmetics Act grants a "valuable statutory right" to manufacturers to have samples independently re-tested. When a drug’s shelf life expires due to the inaction of the prosecuting authority, this right is effectively extinguished, creating irreparable prejudice to the accused.

The Court further noted that the complaint, filed in April 2018, exceeded the three-year limitation period applicable to the alleged offences. With no explanation provided for the delay and no formal record from the trial Magistrate justifying the extension, the institution of the case against the company was deemed legally unsustainable.

Key Observations

The High Court underscored the responsibility of the prosecution in safeguarding the rights of the accused:

  • "Once it is established that valuable right of the accused to adduce evidence in controversion of the Government Analyst 's report is defeated due to acts and omissions of the Drugs Inspector, prosecution against the accused deserves to be quashed ."
  • "There has been delay on the part of the Drugs Inspector in informing the petitioner about the report of the Government Analyst and there has also been inordinate delay on the part of the Drugs Inspector in filing the impugned complaint."
  • "In a case where there is denial of this right on account of the deliberate conduct of the prosecution, we think that the vendor, in his trial, is so seriously prejudiced that it would not be proper to uphold his conviction."

Final Ruling and Implications

The Court concluded that the prosecution’s inability to act with reasonable dispatch constituted an abuse of the process of law. Consequently, the criminal complaint and all proceedings against Dr. Johns Pvt. Ltd. were quashed. This ruling serves as a vital precedent, reinforcing that state agencies must adhere to strict timelines to ensure that the statutory protections afforded to the accused under the Drugs and Cosmetics Act remain functional and effective.